In this interview, Joe Hazelton, President and COO of Dyadic Applied BioSolutions, Inc. (NASDAQ: DYAI), discusses the Company's product-centric strategy, commercialization efforts, strategic partnerships, and opportunities across Life Sciences, Food ...
To better understand their vision, we sat down with PMAX CEO, Geordan Pursglove, to discuss the company’s disruptive strategy and its roadmap for long-term shareholder value. ...
We recently sat down with CEO Leandro Iglesias and his team to discuss IQST's journey, its strategic roadmap, and what sets it apart in the market. ...